Koers Nutritional High International Inc. Canadian Securities Exchange
Aandelen
EAT
CA6706848778
Farmaceutische producten
Omzet 2021 | 96,07K 70,22K 65,25K | Omzet 2022 | 6,25 mln. 4,57 mln. 4,24 mln. | Marktkapitalisatie | 3,26 mln. 2,38 mln. 2,22 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -1 mln. -731K -679K | Nettowinst (verlies) 2022 | -19 mln. -13,89 mln. -12,9 mln. | EV/omzet 2021 | 191 x |
Nettoschuld 2021 | 6,1 mln. 4,46 mln. 4,14 mln. | Nettoschuld 2022 | 11,34 mln. 8,29 mln. 7,7 mln. | EV/omzet 2022 | 2,34 x |
K/w-verhouding 2021 |
-7,32
x | K/w-verhouding 2022 |
-0,09
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 80,7% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 31-03-23 | |
Michael Willetts
DFI | Director of Finance/CFO | - | 31-03-23 |
Adam Szweras
CHM | Chairman | 52 | 07-07-14 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Adam Szweras
CHM | Chairman | 52 | 07-07-14 |
Chief Tech/Sci/R&D Officer | - | 11-06-15 | |
Austin Birch
BRD | Director/Board Member | - | 20-01-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+131,68% | 2,18 mld. | |
+131,75% | 76,48 mln. |